The Latest Breaking News from Palantir

Palantir stock has delivered market-beating returns to shareholders in the last 12 months. However, its steep valuation suggests the tech stock might trail the broader markets if sentiment turns bearish.

Despite Palantir's impressive 66% surge this year, Mizuho downgraded the stock to 'Underperform' due to concerns over high valuation and limited earnings visibility. With mixed analyst ratings and the Q2 earnings report approaching, investors are advised to tread carefully and prepare for potential volatility.

Elon Musk and Peter Thiel, a longtime backer of the new vice-president pick, are among those pledging support

Wedbush Securities analysts led by Dan Ives believe Q2 earnings will be a positive catalyst for tech stocks, which could climb another 15% this year.

Elon Musk's decision to throw his vast fortune behind Donald Trump's presidential candidacy confirms the rise of a growing right-wing bloc in the traditionally liberal Silicon Valley.

Palantir stock could still be cheap here, despite its rise over the past two months ever since releasing its quarterly results. It's projected to make significant free cash flow and FCF margins over the next year.

The military use of AI-enabled weapons is growing, and the industry that provides them is booming

Thursday options trading had nine unusually active call options with more than 365 days to expiration. While they all look intriguing, here are the three to focus on if you’ve got some time to kill.

With the tech landscape increasingly dominated by AI stocks, can Palantir break out in the back of this year?

Palantir Technologies shares have gained over 50% year-to-date amid the AI boom as revenue from government contracts and commercial clients continues to increase steadily.

When US tech giant Palantir signed a £330 million contract with the NHS to operate its data platform, some sounded the alarm over patient privacy.